Author

D. S. Olivier

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 1 Approach:mechanistic / dynamical model· 1 Assay:protein sequence· 1

Frequent Co-Authors

D. Willbold· 2 shared M. S. Amaral· 2 shared R. J. Eberle· 2 shared R. K. Arni· 2 shared H. Schaal· 1 shared I. Gering· 1 shared L. Mueller· 1 shared M. A. Coronado· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

D. Willbold

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Design of D-amino acids SARS-CoV-2 Main protease inhibitors using the cationic peptide from rattlesnake venom as a scaffold

R. J. Eberle, I. Gering, M. Tusche, P. N. Ostermann, L. Mueller, O. Adams, H. Schaal, D. S. Olivier, M. S. Amaral, R. K. Arni, D. Willbold, M. Coronado

The paper designs D-amino acid-based inhibitors of SARS-CoV-2 3CLpro using a rattlesnake venom peptide scaffold, showing in vitro and in vivo antiviral activity.

bioRxiv · Nov 10, 2021Biochemistry

The repurposed drugs suramin and quinacrine inhibit cooperatively in vitro SARS-CoV-2 3CLpro

R. J. Eberle, D. S. Olivier, M. S. Amaral, D. Willbold, R. K. Arni, M. A. Coronado

This study shows that quinacrine and suramin inhibit SARS-CoV-2 3CLpro synergistically in vitro through competitive and non-competitive mechanisms.

bioRxiv · Nov 11, 2020Biochemistry